CRSP
Price
$46.85
Change
+$1.46 (+3.22%)
Updated
Oct 11 closing price
18 days until earnings call
EDIT
Price
$3.19
Change
+$0.23 (+7.77%)
Updated
Oct 11 closing price
25 days until earnings call
Ad is loading...

CRSP vs EDIT

Header iconCRSP vs EDIT Comparison
Open Charts CRSP vs EDITBanner chart's image
CRISPR Therapeutics AG
Price$46.85
Change+$1.46 (+3.22%)
Volume$1.11M
CapitalizationN/A
Editas Medicine
Price$3.19
Change+$0.23 (+7.77%)
Volume$2.27M
CapitalizationN/A
View a ticker or compare two or three
CRSP vs EDIT Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRSP vs. EDIT commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and EDIT is a StrongBuy.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (CRSP: $45.39 vs. EDIT: $2.96)
Brand notoriety: CRSP and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 56% vs. EDIT: 138%
Market capitalization -- CRSP: $4B vs. EDIT: $287.02M
CRSP [@Biotechnology] is valued at $4B. EDIT’s [@Biotechnology] market capitalization is $287.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 1 green, 4 red.
According to our system of comparison, EDIT is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 2 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 2 bullish, 5 bearish.
  • EDIT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а +1.09% price change this week, while EDIT (@Biotechnology) price change was -7.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

EDIT is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4B) has a higher market cap than EDIT($287M). CRSP YTD gains are higher at: -27.492 vs. EDIT (-70.780). EDIT has higher annual earnings (EBITDA): -207.21M vs. CRSP (-335.17M). CRSP has more cash in the bank: 484M vs. EDIT (279M). EDIT has less debt than CRSP: EDIT (38.7M) vs CRSP (231M). CRSP has higher revenues than EDIT: CRSP (200M) vs EDIT (67M).
CRSPEDITCRSP / EDIT
Capitalization4B287M1,394%
EBITDA-335.17M-207.21M162%
Gain YTD-27.492-70.78039%
P/E RatioN/AN/A-
Revenue200M67M299%
Total Cash484M279M173%
Total Debt231M38.7M597%
FUNDAMENTALS RATINGS
CRSP vs EDIT: Fundamental Ratings
CRSP
EDIT
OUTLOOK RATING
1..100
553
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
6391
P/E GROWTH RATING
1..100
85100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (23) in the Biotechnology industry is somewhat better than the same rating for CRSP (63). This means that EDIT’s stock grew somewhat faster than CRSP’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRSP (100). This means that EDIT’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (93) in the Biotechnology industry is in the same range as EDIT (97). This means that CRSP’s stock grew similarly to EDIT’s over the last 12 months.

CRSP's Price Growth Rating (63) in the Biotechnology industry is in the same range as EDIT (91). This means that CRSP’s stock grew similarly to EDIT’s over the last 12 months.

CRSP's P/E Growth Rating (85) in the Biotechnology industry is in the same range as EDIT (100). This means that CRSP’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPEDIT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 24 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.02%
BEAM - CRSP
73%
Closely correlated
-1.75%
NTLA - CRSP
71%
Closely correlated
+0.79%
EDIT - CRSP
68%
Closely correlated
-5.13%
PRME - CRSP
57%
Loosely correlated
+0.56%
RXRX - CRSP
56%
Loosely correlated
+0.49%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with NTLA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-5.13%
NTLA - EDIT
75%
Closely correlated
+0.79%
CRSP - EDIT
68%
Closely correlated
-0.02%
BEAM - EDIT
67%
Closely correlated
-1.75%
ALLO - EDIT
55%
Loosely correlated
-0.76%
ALEC - EDIT
55%
Loosely correlated
-7.89%
More